Compound Detail
CHEMBL353263
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL353263 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FVJUKGHGMMHNHD-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
431.4
MW (Da)
2.98
ALogP
6
HBA
3
HBD
115.1
PSA (Ų)
0.42
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.3
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 50.0 | nM | 7.3 | Inhibition of LTB4 biosynthesis in bovine polymorphonuclear leukocytes using nor... | 11262091 |
| ADMET | IC50 | = | 700.0 | nM | 6.16 | Concentration required to inhibit 50% growth of HaCaT cells | 11262091 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11262091 | 10.1021/jm001073w | ADMET | 5 |
| 11262091 | 10.1021/jm001073w | Unchecked | 2 |
| 11262091 | 10.1021/jm001073w | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine